Lin YC - Search Results

1

Telehealth for the management of patients with type 2 diabetes in remote areas of Taiwan: a best practice implementation project.

Tsay SF, Chang HC, Mu PF, Chou PL, Lin YC, Lin JH. Tsay SF, et al. Among authors: lin yc. JBI Evid Implement. 2025 Jul 4. doi: 10.1097/XEB.0000000000000519. Online ahead of print. JBI Evid Implement. 2025. PMID: 40607731

2

FGFR inhibitors promote the autophagic degradation of IFN-γ-induced PD-L1 and alleviate the PD-L1-mediated transcriptional suppression of FGFR3-TACC3 in non-muscle-invasive bladder cancer.

Lin YC, Chu CY, Hsieh TH, Lin BJ, Liou JP, Yen Y, Chen CH. Lin YC, et al. Cell Death Dis. 2025 Jul 2;16(1):485. doi: 10.1038/s41419-025-07821-8. Cell Death Dis. 2025. PMID: 40603902 Free article.

3

Prognostic utility of ¹⁸F-FDG PET/MRI with intravoxel incoherent motion imaging in nasopharyngeal carcinoma.

Chan SC, Ng SH, Yeh CH, Lin YC, Lin CY, Wang JH, Cheng NM, Chen SH, Chang KP, Hsieh JC. Chan SC, et al. Among authors: lin yc. Eur J Nucl Med Mol Imaging. 2025 Jul 2. doi: 10.1007/s00259-025-07425-6. Online ahead of print. Eur J Nucl Med Mol Imaging. 2025. PMID: 40601020

4

Tricin selectively combats KRAS-mutant non-small cell lung cancer by inhibiting the PDGF-BB-induced SRC/MAPK/AP-1/PD-L1 signaling pathway and potentiating the antitumor effect of an anti-PD-1 antibody.

Li JX, Tan SY, Li LQ, Zheng YH, Zhao L, Zhu HR, He HL, Zhang YY, Li RZ, Bao TY, Zhang YZ, Yang XM, Zhang H, Chen HH, Wu BW, Lin X, Lin XS, Lin YC, Sui XB, Xie Y, Zhou XM, Yan PY. Li JX, et al. Among authors: lin yc. Front Pharmacol. 2025 Jun 17;16:1594213. doi: 10.3389/fphar.2025.1594213. eCollection 2025. Front Pharmacol. 2025. PMID: 40599804 Free PMC article.

5

Baseline serum EV-miR-1-3p as a protective factor and biomarker for hepatocellular carcinoma development after HCV eradication.

Teng W, Ku WT, Lin PT, Chen GT, Chu LJ, Liu H, Lin YC, Lin CY. Teng W, et al. Among authors: lin yc. J Transl Med. 2025 Jul 1;23(1):722. doi: 10.1186/s12967-025-06765-z. J Transl Med. 2025. PMID: 40598241 Free PMC article.

6

Efficacy of cefoperazone-sulbactam as a component of combination therapy for carbapenem-resistant Acinetobacter baumannii bloodstream infection in intensive care units: a multicenter retrospective propensity score-matched study.

Wang SH, Lin YC, Chan MC, Yang KY, Sheu CC, Wu BR, Huang WH, Feng JY, Chen CM, Weng ZX, Peng CK, Tang SE; and the T-CARE (Taiwan Critical Care and Infection) Group. Wang SH, et al. Among authors: lin yc. BMC Infect Dis. 2025 Jul 1;25(1):872. doi: 10.1186/s12879-025-11205-w. BMC Infect Dis. 2025. PMID: 40597720 Free PMC article.

7

Hinokiflavone is a novel CK2 inhibitor promoting apoptosis and synergizing with chemotherapeutic agents in cisplatin resistant bladder cancer cells.

Hsieh TH, Kuo HP, Chen MC, Lin YC, Lin BJ, Hsu KC, Chen CH. Hsieh TH, et al. Among authors: lin yc. Sci Rep. 2025 Jul 1;15(1):20922. doi: 10.1038/s41598-025-06543-3. Sci Rep. 2025. PMID: 40594996 Free PMC article.

8

Tumor-migrating peripheral Foxp3-high regulatory T cells drive poor prognosis in hepatocellular carcinoma.

Huang CH, Ku WT, Mahalingam J, Wu CH, Wu TH, Fan JH, Su CW, Lin PT, Peng CW, Yang CK, Teng W, Jeng WJ, Chen WT, Lin CC, Lin SM, Sheen IS, Lin YC, Lin CY. Huang CH, et al. Among authors: lin yc. Hepatology. 2025 Jul 1. doi: 10.1097/HEP.0000000000001428. Online ahead of print. Hepatology. 2025. PMID: 40590861

9

Inertial sensor-based gait classification for frailty status in older adults: A cross-sectional study.

Lien WC, Wang WF, Chang CH, Liu B, Yang YC, Yang TH, Kuan TS, Wang WM, Huang W, Shahmirzadi D, Lin YC. Lien WC, et al. Among authors: lin yc. Comput Struct Biotechnol J. 2025 May 28;28:199-210. doi: 10.1016/j.csbj.2025.05.011. eCollection 2025. Comput Struct Biotechnol J. 2025. PMID: 40585381 Free PMC article.

10

Dapagliflozin Interrupts Pro-Fibroinflammatory Interleukin 11-Tenascin C Mutual Reinforcement in Fibroblasts by Antagonizing Interleukin-11 Receptor Subunit Alpha.

Lin YC, Chen WJ, Hsu YJ, Lai YJ, Kuo CC, Yeh YH. Lin YC, et al. J Cell Physiol. 2025 Jun;240(6):e70052. doi: 10.1002/jcp.70052. J Cell Physiol. 2025. PMID: 40583258

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,732 results

Search Page

Filters